课题基金 / 基金详情

Automated image-based biomarker computation tools for diabetic retinopathy

Automated image-based biomarker computation tools for diabetic retinopathy
用于糖尿病视网膜病变的基于图像的自动化生物标志物计算工具
批准号:
8252674
负责人:
Kaushal Solanki
金额:
$26.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2013-11-30

项目摘要

项目成果

Kaushal Solanki的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在这个STTR项目中,我们介绍了一套工具EyeMark,用于使用视网膜图像照片自动计算糖尿病视网膜病变的生物标记物。具体地说,我们将开发计算微动脉瘤(MA)出现和消失率(统称为周转率)的工具,作为监测糖尿病视网膜病变(DR)进展的生物标志物。可靠的基于图像的生物标记物的可用性将对DR护理的各个方面产生高度积极的影响,包括筛查、监测进展、药物发现和临床研究。已发表的大量证据表明,MA周转率是发展为更严重视网膜病变的可能性的良好预测指标,从而确立MA周转率是糖尿病视网膜病变的良好生物标志物。测量这一数量包括两个步骤:仔细对当前和基线图像进行对齐,以及对单个mA进行标记。如果完全由人类评分员来完成,这个过程非常耗时,而且容易出错。该项目的主要目标是通过自动化MA营业额测量中涉及的两个步骤来克服上述限制:准确的图像配准和MA检测。我们将开发用于自动计算MA营业额的端到端桌面软件,并为临床医生提供直观的可视化工具,以更有效地监控糖尿病视网膜病变的进展。 公共卫生相关性:通过提供一个以非侵入性方式计算生物标记物的自动化工具,建议的工具将极大地增强糖尿病视网膜病变患者的临床护理。这将有助于识别哪些患者更有可能进展为严重的视网膜病变,从而通过及时的干预帮助防止此类患者的视力丧失。面对等待眼科检查的糖尿病患者的长期积压,以及90%的视力损失可以通过早期识别来挽救的事实,及早识别尤为重要。有效的生物标记物的可获得性也将通过促进早期和可靠地确定潜在新疗法的生物疗效而对药物发现过程产生积极影响。
英文摘要
DESCRIPTION (provided by applicant): In this STTR project, we present EyeMark, a set of tools for automated computation of biomarkers for diabetic retinopathy using retinal image photographs. Specifically, we will develop tools for computation of microaneurysm (MA) appearance and disappearance rates (jointly known as turnover rates) for use as a biomarker in monitoring progression of diabetic retinopathy (DR). The availability of a reliable image-based biomarker will have high positive influence on various aspects of DR care, including screening, monitoring progression, drug discovery and clinical research. There is ample published evidence that MA turnover rates are a good predictor of likelihood of progression to more severe retinopathy, establishing MA turnover as an excellent biomarker for diabetic retinopathy. Measuring this quantity involves two steps: careful alignment of current and baseline images, and marking of individual MAs. This process is very time consuming and prone to error, if done by entirely by human graders. The primary goal of this project is to overcome the above limitations by automating both the steps involved in MA turnover measurement: accurate image registration, and MA detection. We will develop end-too-end desktop software for automated computation of MA turnover and also provide intuitive visualization tools for clinicians to more effectively monitor diabetic retinopathy progression. PUBLIC HEALTH RELEVANCE: The proposed tool will greatly enhance the clinical care available to diabetic retinopathy patients by providing an automated tool for computation of a biomarker in a non-invasive manner. This will enable identification of patients who are more likely to progress to severe retinopathy, thus helping prevent vision loss in such patients by timely intervention. Early identification is especially important in face of long backlog of diabetic patients waiting for an eye examination, and the fact that 90% of vision loss can be saved by early identification. The availability of an effective biomarker will also positively influence the drug discovery process by facilitating early and reliable determination of biological efficacy of potential new therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Application
  • 批准号:
    9142236
  • 项目类别:
  • 资助金额:
    $98.4万
  • 财政年份:
    2016
  • 负责人:
    Kaushal Solanki
  • 依托单位:
Mobile App for Diabetic Retinopathy Screening using Cellphone Retinal Camera
  • 批准号:
    8782362
  • 项目类别:
  • 资助金额:
    $21.7万
  • 财政年份:
    2014
  • 负责人:
    Kaushal Solanki
  • 依托单位:
Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Applications
  • 批准号:
    8266132
  • 项目类别:
  • 资助金额:
    $19.99万
  • 财政年份:
    2012
  • 负责人:
    Kaushal Solanki
  • 依托单位:
Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy
  • 批准号:
    8782297
  • 项目类别:
  • 资助金额:
    $49.08万
  • 财政年份:
    2012
  • 负责人:
    Kaushal Solanki
  • 依托单位:
海外基金